Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/74562
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAmro M. Solimanen_US
dc.contributor.authorRu Hui Simen_US
dc.contributor.authorSrijit Dasen_US
dc.contributor.authorPasuk Mahakkanukrauhen_US
dc.date.accessioned2022-10-16T06:43:57Z-
dc.date.available2022-10-16T06:43:57Z-
dc.date.issued2022-05-01en_US
dc.identifier.issn1875533Xen_US
dc.identifier.issn09298673en_US
dc.identifier.other2-s2.0-85130285474en_US
dc.identifier.other10.2174/0929867328666210910154330en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85130285474&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/74562-
dc.description.abstractThere is an increase in the incidence of inflammatory eye diseases worldwide. Several dysregulated inflammatory pathways, including the NOD-like receptor protein 3 (NLRP3) inflammasome, have been reported to contribute significantly to the pathogenesis and progression of ophthalmic diseases. Although the available allopathic/ conventional medicine has demonstrated effectiveness in managing eye diseases, there is an ongoing global demand for alternative therapeutics with minimal adverse drug reactions, easy availability, increase in patient compliance, and better disease outcomes. Therefore, several studies are investigating the utilization of natural products and herbal formulations in impeding inflammatory pathways, including the NLRP3 inflammasome, in order to prevent or manage eye diseases. In the present review, we highlight the recently reported inflammatory pathways with special emphasis on NLRP3 Inflammasomes involved in the development of eye diseases. Furthermore, we present a variety of natural products and phytochemicals that were reported to interfere with these pathways and their underlying mechanisms of action. These natural products represent potential therapeutic applications for the treatment of several inflammatory eye diseases.en_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectChemistryen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleTherapeutic Targeting of Inflammatory Pathways with Emphasis on NLRP3 Inflammasomes by Natural Products: A Novel Approach for the Treatment of Inflammatory Eye Diseasesen_US
dc.typeJournalen_US
article.title.sourcetitleCurrent Medicinal Chemistryen_US
article.volume29en_US
article.stream.affiliationsSultan Qaboos Universityen_US
article.stream.affiliationsUniversity of Albertaen_US
article.stream.affiliationsChiang Mai Universityen_US
article.stream.affiliationsTanglin Health Clinicen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.